Escarpment Cancer Research Institute Launched!

Inspiring Research: Because Every Patient Matters

November 01, 2011 | Blog

Officially launched as a joint McMaster University/Hamilton Health Sciences Research Institute in September 2011, the Escarpment Cancer Research Institute (ECRI) represented the coming together of a cadre of 17 clinical and health services researchers deeply committed to making a difference in the lives of cancer patients and their families.

This core group of scientists has a strong track record of peer-reviewed funding. ECRI incorporated and built-on several already well-established research units (Program in Evidence Based Care {PEBC}, Ontario Clinical Oncology Group {OCOG}, Supportive Cancer Care Research {SCCR} Unit, and the Canadian Centre of Excellence in Advanced Practice Nursing). ECRI members hold several career awards including two endowed McMaster chairs (Levine, Muti), a Canada Research Chair (Whelan), a Cancer Care Ontario Research Chair (Seow), and two Ontario Institute for Cancer Research Career Scientist positions (Juergens, Bane).

Complementing this core team are several associate members that bring strength in Nuclear Medicine and Immunology and strengthen the links between the Juravinski Cancer Centre (JCC) Disease Site Groups and ECRI. Disciplines represented in ECRI include Medical Oncology (Levine, Hotte, Hirte, Arnold and Juergens), Radiation Oncology (Whelan, Sussman), Gynecological Oncology (Elit), Surgical Oncology (Simunovic), Anatomical Pathology (Bane), Clinical Chemistry (Kavsak), Nursing (Bryant-Lukosius), Psychology (Brouwers), Health Policy (Seow), Cancer Epidemiology (Muti), and Biostatistics (Julian, Pond). Two members hold Cancer Care Ontario provincial leadership roles in Cervical Screening (Elit), and Cancer Survivorship (Sussman). Members of ECRI have expertise in several clinical foci such as breast cancer, lung cancer, colorectal cancer and gynecological cancers, as well as strength in multiple methodologies including the design and conduct of randomized controlled trials, program evaluation, guideline development and knowledge translation.

This combination of scientific expertise and clinical foci creates a unique and exciting milieu where important clinical and system issues related to cancer care that are meaningful and critical to the JHCC and our regional cancer program can be explored with a view to either bringing existing research to bear through knowledge translation strategies or formulating research questions that may bring new research funding to ECRI and the cancer program and advance knowledge in ways that are meaningful to our patients, to the health care providers who care for them, and to the decision makers who shape the system either at the policy or delivery level.